Related Tags >> schizophrenia FDA approval Janssen FDA

RISPERDAL News

Most Popular RISPERDAL Story

ALSO NOTED: FDA rejects Risperdal for Alzheimer's; Elan CEO bullish on Tysabri's return; Myogen, Novartis expand pact; and much

May 25, 2005 — 8:00pm ET

> Johnson & Johnson says the FDA has turned thumb's down on Risperdal as a treatment of psychosis in Alzheimer's. Read more...

RISPERDAL Press Releases

Ortho-McNeil-Janssen Pharmaceuticals, Inc. Release: FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia
FDA Issues Approvable Letter for RISPERDAL® to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Ma
PRESS RELEASE: FDA Approves RISPERDAL to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania

Latest Headlines

ALSO NOTED: FDA rejects Risperdal for Alzheimer's; Elan CEO bullish on Tysabri's return; Myogen, Novartis expand pact; and much
May 25, 2005

Paid Research Reports